(Q44756644)

6 December 2017

title

Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial (English)

1 reference

6 December 2017

1 reference

1 reference

R J Millard

1

1 reference

6 December 2017

K Moore

2

1 reference

6 December 2017

R Rencken

3

1 reference

6 December 2017

I Yalcin

4

1 reference

6 December 2017

R C Bump

5

1 reference

6 December 2017

Duloxetine UI Study Group

6

1 reference

6 December 2017

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

93

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

311-318

1 reference

Definition of overactive bladder and epidemiology of urinary incontinence

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N,N-dimethyltryptamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

α2-Adrenoceptors not imidazole receptors mediate depression of a sacral spinal reflex in the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Duloxetine versus placebo in the treatment of stress urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Quality of life of persons with urinary incontinence: development of a new measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Validation of two global impression questionnaires for incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

LY248686, a new inhibitor of serotonin and norepinephrine uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04607.X

10.1111/J.1464-410X.2004.04607.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference